Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

Home Clinical Trials at Duke Clinical Trials Directory

Phyllodes Gene Testing - Clinical Trial

What is the Purpose of this Study?

We are doing this study to screen women that have diagnosed with phyllodes tumor of the breast for genetic mutations that may be linked with a future risk of cancer.
What is the Condition Being Studied?
Phyllodes tumor

Who Can Participate in the Study?

- Female diagnosed with phyllodes tumor
- 18 years or older

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Give saliva for genetic testing
- Get a copy of the results
- Get genetic counseling after your results

Study Details

Full Title
Multi-Gene Panel Testing for Germline Mutations in a Contemporary Cohort of Patients with Phyllodes Tumors of the Breast
Principal Investigator
Laura H. Rosenberger, MD, MS
Surgical Oncologist
Protocol Number
IRB: PRO00103750
Phase
Phase N/A
Learn More About Clinical Trials at Duke
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698